Description  Claims  Drawing  Cited references 

WO2010132428A1   [0009] 
US8535641B   [0009] 
US2011064661A1   [0009] 
US20140030187   [0009] 

Canc Res   [0006] 
Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma   [0006] 
Alkylphosphocholine analogs for broad-spectrum cancer imaging and therapy   [0009] 
Design of self-immolative linkers for tumour-activated prodrug therapy   [0058] 
β-glucuronidase- responsive prodrugs for selective cancer chemotherapy: An update   [0059] 
Methods in Cell Biology   [0083] 
CRC Crit. Ref. Biomed. Eng.   [0084] 
Surgery   [0084] 
N. Engl. J. Med.   [0084] 
Medical Applications of Controlled Release   [0084] 
Science   [0084] 
Int J Pharm   [0117] 
Can J Chem   [0120] 
Org Lett   [0120] 
Intracranial C6 glioma model in adult Wistar-Furth rats   [0137] 
Int J Appl Rad Isotopes   [0139]